Literature DB >> 22421986

Differential diagnosis of hyperandrogenism in women with polycystic ovary syndrome.

D Rachoń1.   

Abstract

According to the Androgen Excess and Polycystic Ovary Syndrome Society (AE&PCOS), the main feature of PCOS is clinical hyperandrogenism or laboratory hyperandrogenaemia. Therefore, in diagnosing PCOS one must always exclude other causes of androgen excess. In a woman with hyperandrogenism, the diagnosis of PCOS can usually be made according to the patient's history and careful clinical examination. Signs of mild hyperandrogenaemia usually start after the menarche and cycles continue to be anovulatory in adult life. Non-classical congenital adrenal hyperplasia (NCCAH) can be another cause of hyperandrogenism with oligomenorrhea. This can be diagnosed in a patient with elevated basal or ACTH stimulated serum 17OH-progesterone (17-OHP) levels or in a case of a significant decrease in serum testosterone (TST) and dehydroepiandrosterone sulphate (DHEA-S) in a two day dexamethasone suppression test. Cushing's disease (ACTH producing pituitary adenoma) is a rare cause of hyperandrogenaemia in women with recent onset of hyperandrogenism. However, it must always be taken into the consideration in a patient with accompanying signs of hypercortisolism. It can usually be excluded by performing an overnight dexamethasone suppression test or the measurement of 24 h urinary free cortisol levels. Severe signs of hyperandrogenism which lead to virilization should always lead to the exclusion of androgen secreting tumors of ovarian or adrenal origin. These are very rare but should be always taken into the account in a patient with recent onset of severe signs of androgen excess and very high serum androgen levels. Mild signs of hyperandrogenaemia in a woman with recent oligomenorrhea should always lead to the exclusion of hyperprolactinaemia. © J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22421986     DOI: 10.1055/s-0031-1299765

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  6 in total

1.  Successful laparoscopic resection of virilizing ovarian steroid cell tumor, not otherwise specified, in a 22-year-old woman: a case report and evaluation of the steroidogenic pathway.

Authors:  Jun Matsukawa; Toshifumi Takahashi; Yurika Hada; Wataru Kameda; Kuniaki Ota; Mika Fukase; Kyoko Takahashi; Koki Matsuo; Hideki Mizunuma; Satoru Nagase
Journal:  Fukushima J Med Sci       Date:  2019-12-11

2.  Effect of lifestyle intervention on the reproductive endocrine profile in women with polycystic ovarian syndrome: a systematic review and meta-analysis.

Authors:  Liza Haqq; James McFarlane; Gudrun Dieberg; Neil Smart
Journal:  Endocr Connect       Date:  2014-02-28       Impact factor: 3.335

3.  Insulin resistance enhances the mitogen-activated protein kinase signaling pathway in ovarian granulosa cells.

Authors:  Linghui Kong; Qien Wang; Jiewen Jin; Zou Xiang; Taoyu Chen; Shanmei Shen; Hongwei Wang; Qian Gao; Yong Wang
Journal:  PLoS One       Date:  2017-11-10       Impact factor: 3.240

4.  Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS.

Authors:  Fu Chen; Minjie Chen; Weichun Zhang; Huihuang Yin; Guishan Chen; Qingxia Huang; Xiaoping Yang; Lan Chen; Chujia Lin; Guoshu Yin
Journal:  J Ovarian Res       Date:  2021-02-14       Impact factor: 4.234

5.  Associations of diet, physical activity and polycystic ovary syndrome in the Coronary Artery Risk Development in Young Adults Women's Study.

Authors:  Annie W Lin; David Siscovick; Barbara Sternfeld; Pamela Schreiner; Cora E Lewis; Erica T Wang; Sharon S Merkin; Melissa Wellons; Lyn Steffen; Ronit Calderon-Margalit; Patricia A Cassano; Marla E Lujan
Journal:  BMC Public Health       Date:  2021-01-06       Impact factor: 3.295

6.  The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report.

Authors:  Larisa V Suturina; Eldar M Sharifulin; Maharam A Sharifulin; Ludmila M Lazareva; Irina N Danusevich; Kseniia D Ievleva; Iana G Nadeliaeva
Journal:  Metabolites       Date:  2022-07-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.